Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

NCT ID: NCT05270616

Last Updated: 2022-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-01

Study Completion Date

2028-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection.

Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Diseases Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

robotic surgery group

minimally invasive lung surgery using the Davinci robotic system to assist.

Group Type EXPERIMENTAL

robotic surgery

Intervention Type PROCEDURE

minimally invasive surgery using the Davinci robotic system

uniport surgery group

VATS minimally invasive lung surgery under the uniportal status.

Group Type ACTIVE_COMPARATOR

uniport surgery

Intervention Type PROCEDURE

VATS minimally invasive surgery under the uniportal status

multiple- port surgery group

VATS minimally invasive lung surgery under the multiple- port status.

Group Type ACTIVE_COMPARATOR

multiple- port surgery

Intervention Type PROCEDURE

VATS minimally invasive surgery under the multiple- port status

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

robotic surgery

minimally invasive surgery using the Davinci robotic system

Intervention Type PROCEDURE

uniport surgery

VATS minimally invasive surgery under the uniportal status

Intervention Type PROCEDURE

multiple- port surgery

VATS minimally invasive surgery under the multiple- port status

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. good cardio- pulmonary function to tolerate surgery;
2. minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy;

Exclusion Criteria

1. cardio- pulmonary function is not good enough to tolerate surgery;
2. huge tumor or extensive adhesion in thoracic cavity.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Second Hospital of Shandong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Second Hospital of Shandong University

Jinan, Shandong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiaogang Zhao

Role: CONTACT

+8617660080007

Yunpeng Zhao

Role: CONTACT

18766188692

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yunpeng Zhao, doctor

Role: primary

+8618766188692

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Robotic lung ZYP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.